Traditionally, licorice has been used to treat many diseases. A clinical trial found that glycyrrhizin, the main constituent of licorice, had low oral bioavailability in humans. Scientific validation has proven licorice is effective against different diseases. The main constituents of licorice - glycyrrhizic acid, 18-β-glycyrrhetinic acid, glycyrrhizin and licochalcones - have pharmacological effects including antimicrobial, antioxidant, and anti-inflammatory properties. High doses of glycyrrhizin can cause side effects and interactions with other drugs.
Traditionally, licorice has been used to treat many diseases. A clinical trial found that glycyrrhizin, the main constituent of licorice, had low oral bioavailability in humans. Scientific validation has proven licorice is effective against different diseases. The main constituents of licorice - glycyrrhizic acid, 18-β-glycyrrhetinic acid, glycyrrhizin and licochalcones - have pharmacological effects including antimicrobial, antioxidant, and anti-inflammatory properties. High doses of glycyrrhizin can cause side effects and interactions with other drugs.
Traditionally, licorice has been used to treat many diseases. A clinical trial found that glycyrrhizin, the main constituent of licorice, had low oral bioavailability in humans. Scientific validation has proven licorice is effective against different diseases. The main constituents of licorice - glycyrrhizic acid, 18-β-glycyrrhetinic acid, glycyrrhizin and licochalcones - have pharmacological effects including antimicrobial, antioxidant, and anti-inflammatory properties. High doses of glycyrrhizin can cause side effects and interactions with other drugs.
Traditional Use Reference Scientific Validation Research-Based Reference
Use Type of Brief description of the Result study (In study vitro/in vivo/clinical trial Traditionally, It’s a clinical n Humans As a Glycyrrhizic licorice has been trial Glycyrrhizin, the main result, acid, 18-β- reported to constituent licorice, from glycyrrhetinic treat many showed impaired oral scientific acid, glycyrrhizin diseases, such as bioavailability in humans validatio and asthma, and it was found at very n it is licochalcones tonsillitis, sore low concentrations after proved are the main throat, oral administration. After that the constituents hyperdipsia, oral administration of licorice is that have been flatulence, licorice, glycyrrhizic acid very isolated from G. epilepsy, fever, is hydrolyzed to 18β- effective glabra extracts. sexual debility, glycyrrhizic acid by the to Pharmacological paralysis, action of intestinal overcom ly, G. glabra and coughs, stomach bacteria, which e the its main ulcers, influences a specialized different constituents heartburn, colic, β-D-glucuronidase [23]. diseases. possess swellings, Glycyrrhizin acid antimicrobial, rheumatism, pharmacokinetics, after antiparasitic, skin diseases, oral ingestion, are more antiviral, acidity, relevant than glycyrrhizic antitussive, leucorrhoea, acid as they show 200– immuno- bleeding, 1000 times stronger 11 β- enhancing, hemorrhagic HSDs inhibition. antioxidant, diseases, and Afterward, glycyrrhetic anti- jaundice acid is rapidly absorbed inflammatory, [28,29,30,31,32] and transferred by carrier and anticancer . Moreover, it molecules to the liver effects. was traditionally where it is metabolized Moreover, they used as an by lysosomal β-D- show insecticide, glucuronidase to 3- hepatoprotectiv laxative, anti- mono-glucuronide 18β- e, anticoagulant, inflammatory, glycyrrhetinic acid and antidiabetic, anti-ulcer, sulfate conjugates, which and spasmolytic antibiotic, anti- subsequently re-degrade activities. arthritic, to glycyrrhetic acid and Glycyrrhizin, the antiviral, are reabsorbed, leading main active memory to a significant delay in constituent stimulant, terminal plasma of G. glabra, is anticancer, and clearance [111]. Neither contraindicated anti-diuretic glycyrrhizin nor 18 β- for agent [33]. It is glycyrrhetinic acid have administration used in the been documented to with oral confection cumulate in tissues. The contraceptives, industry, such as plasma clearance of hydrocortisone, in soft drinks, glycyrrhizin and 18 β- and sweets, and glycyrrhetinic acid is only prednisolone. alcohol and the dose-dependent at high Administration tobacco doses that exceed the of high doses of industry. serum protein binding glycyrrhizin saturation, while it is not causes pseudo dose-dependent at low aldosteronism doses below 120 mg in that may leads healthy people [19]. to several Previous studies adverse effects. documented that glycyrrhizin and 18 β- glycyrrhetinic acid pharmacokinetics could be affected by other phytochemical compounds present in licorice extracts. For instance, Isbrucker and Burdock [19] reported that glycyrrhizin and 18 βglycyrrhetinic acid concentrations, after aqueous licorice root extract administration to rats and humans, were low when compared to pure glycyrrhizin single therapy and significant variations were observed in the Tmax, areas under the plasma-time curve (AUC), and Cmax parameters. Moreover, Ploeger et al. [111] revealed that the plasma clearance of 18β- glycyrrhetinic acid decreases significantly in chronic hepatitis C and liver cirrhosis patients, indicating that the liver capacity is limited in 18 β-glycyrrhetinic acid metabolism and/or excretion in the bile. Notably, 18 β- glycyrrhetinic acid has also been documented to penetrate the placental barrier and this could be observed in the rat fetuses [111].